Tolvaptan treatment is associated with altered mineral metabolism parameters and increased bone mineral density in ADPKD patients.
Nephrol Dial Transplant
; 38(7): 1645-1654, 2023 Jun 30.
Article
in En
| MEDLINE
| ID: mdl-36309473
Full text:
1
Database:
MEDLINE
Main subject:
Polycystic Kidney, Autosomal Dominant
Type of study:
Observational_studies
/
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
Nephrol Dial Transplant
Journal subject:
NEFROLOGIA
/
TRANSPLANTE
Year:
2023
Type:
Article
Affiliation country:
Switzerland